aezs 124 has been researched along with phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 in 2 studies
Studies (aezs 124) | Trials (aezs 124) | Recent Studies (post-2010) (aezs 124) | Studies (phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2) | Trials (phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2) | Recent Studies (post-2010) (phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2) |
---|---|---|---|---|---|
10 | 0 | 2 | 17 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Comaru-Schally, AM; Halmos, G; Irimpen, A; Nagy, A; Schally, AV | 1 |
Halmos, G; Rick, FG; Schally, AV; Seitz, S; Szalontay, L; Szepeshazi, K; Treszl, A | 1 |
2 other study(ies) available for aezs 124 and phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2
Article | Year |
---|---|
Absence of binding of targeted analogs of somatostatin carrying cytotoxic radicals or radionuclides to growth hormone secretagogue receptors on human myocardium.
Topics: 2-Hydroxyphenethylamine; Aged; Aniline Compounds; Doxorubicin; Humans; Indium Radioisotopes; Male; Middle Aged; Myocardium; Octreotide; Pyrroles; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Somatostatin | 2003 |
Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.
Topics: 2-Hydroxyphenethylamine; Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Binding, Competitive; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Membrane; Cell Survival; Down-Regulation; Doxorubicin; Drug Carriers; Gene Expression; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Octreotide; Receptors, Somatotropin; Somatostatin; Up-Regulation; Xenograft Model Antitumor Assays | 2009 |